J&J Unit Recalls Antipsychotic Syringes Over Cracks

Law360, New York (February 16, 2011, 6:42 PM EST) -- Johnson & Johnson unit Janssen has voluntarily recalled 70,000 syringes with the antipsychotic drug Invega Sustenna, saying some may contain cracks that pose a possible infection risk.

Titusville, N.J.-based Janssen, part of the pharmaceutical and medical device giant's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary, published a letter dated Friday saying it had recalled 10 lots of 234-milligram doses of its Invega Sustenna, or paliperidone palmitate, extended-release injectable suspension.

Some of the prefilled syringes could contain a crack in the syringe barrel that would not be detectable by the...
To view the full article, register now.